Elanco Animal Health's Common Equity rose 3.46% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 billion, marking a year-over-year increase of 3.46%. This contributed to the annual value of $6.1 billion for FY2024, which is 2.04% down from last year.
As of Q3 2025, Elanco Animal Health's Common Equity stood at $6.7 billion, which was down 0.38% from $6.8 billion recorded in Q2 2025.
In the past 5 years, Elanco Animal Health's Common Equity ranged from a high of $8.0 billion in Q1 2021 and a low of $5.9 billion during Q2 2024.
For the 3-year period, Elanco Animal Health's Common Equity averaged around $6.5 billion, with its median value being $6.4 billion (2025).
Its Common Equity has fluctuated over the past 5 years, first rose by 20.21% in 2021, then fell by 19.92% in 2024.
Over the past 5 years, Elanco Animal Health's Common Equity (MRQ) stood at $7.5 billion in 2021, then dropped by 2.92% to $7.3 billion in 2022, then dropped by 14.62% to $6.2 billion in 2023, then decreased by 2.04% to $6.1 billion in 2024, then grew by 10.71% to $6.7 billion in 2025.
Its last three reported values are $6.7 billion in Q3 2025, $6.8 billion for Q2 2025, and $6.4 billion during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value